UK markets closed

Burning Rock Biotech Limited (BNR)

NasdaqGM - NasdaqGM Delayed price. Currency in USD
Add to watchlist
0.7930+0.0135 (+1.73%)
At close: 04:00PM EDT
0.8038 +0.01 (+1.36%)
After hours: 07:02PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 81.35M
Enterprise value -2.13M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.09
Price/book (mrq)0.76
Enterprise value/revenue 0.31
Enterprise value/EBITDA -0.17

Trading information

Stock price history

Beta (5Y monthly) 0.18
52-week change 3-72.18%
S&P500 52-week change 326.27%
52-week high 32.9200
52-week low 30.5720
50-day moving average 30.7634
200-day moving average 30.9710

Share statistics

Avg vol (3-month) 352.24k
Avg vol (10-day) 365.46k
Shares outstanding 5102.59M
Implied shares outstanding 6102.59M
Float 855.31M
% held by insiders 10.12%
% held by institutions 160.93%
Shares short (30 Apr 2024) 4402.41k
Short ratio (30 Apr 2024) 415.42
Short % of float (30 Apr 2024) 40.45%
Short % of shares outstanding (30 Apr 2024) 40.39%
Shares short (prior month 28 Mar 2024) 4405.4k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in CNY.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -121.63%
Operating margin (ttm)-137.36%

Management effectiveness

Return on assets (ttm)-31.84%
Return on equity (ttm)-67.85%

Income statement

Revenue (ttm)537.44M
Revenue per share (ttm)5.25
Quarterly revenue growth (yoy)-14.90%
Gross profit (ttm)N/A
EBITDA -537.87M
Net income avi to common (ttm)-653.69M
Diluted EPS (ttm)-0.8800
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)628.5M
Total cash per share (mrq)6.13
Total debt (mrq)12.32M
Total debt/equity (mrq)1.60%
Current ratio (mrq)3.36
Book value per share (mrq)7.50

Cash flow statement

Operating cash flow (ttm)-255.78M
Levered free cash flow (ttm)-57.45M